how do glp-1 agonists work for diabetes GLP1 Receptor Agonists—Effects beyond Obesity and Glucagon-like peptide-1 - Wikipedia
Description
Patients with type 2 diabetes, especially those with cardiovascular disease, chronic kidney disease, obesity, or NAFLD, may benefit from GLP-1 receptor agonists as part of their treatment regimen
World Health Organization, Obesity and overweight. June 9, 2021
For long-term cholesterol management, many patients find that GLP-1 therapy, combined with healthier eating patterns and regular physical activity, creates lasting improvements in their cardiovascular risk profile
The hazard ratio and 95% confidence interval did not reveal a significant difference between tirzepatide or insulin glargine treatment (HR, 0.74
Important Notice This page is provided for informational purposes only
